Loading...
Next generation chimeric antigen receptor T cells: safety strategies to overcome toxicity
Chimeric antigen receptor T (CAR-T) cell therapy is an emerging and effective cancer immunotherapy. Especially in hematological malignancies, CAR-T cells have achieved exciting results. Two Anti-CD19 CAR-T therapies have been approved for the treatment of CD19-positive leukemia or lymphoma. However,...
Saved in:
| Published in: | Mol Cancer |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6701025/ https://ncbi.nlm.nih.gov/pubmed/31429760 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-019-1057-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|